维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Ruf RG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Prevalence of WTI mutations in a large cohort of patients with steroid - resistant and steroid - sensitive nephrotic syndrome 显示文摘	Ruf RG Schultheiss M	2004	Kidney Int2004，66，2：	1
2	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome 显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，3：	1
3	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotie syndrome 显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，3：	1
4	SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes显示文摘	Ruf RG Xu PX Silvius D	2004	Proc Natl Acad Sci USA2004，101，21：	1
5	S1X1 mutations cause branchio--oto--renal syndrome by disruption of EYA1- SIXl-DNA complexes显示文摘	Ruf RG Xu PX Silvius D	2004	Proe Natl Acad Sci USA2004，1018，090：	1
6	SIX1 mutations cause branchiooto-renal syndrome by disruption of EYA1-SIX1-DNA complexes显示文摘	Ruf RG Xu PX Silvius D	2004	Proc Natl Acad Sci U S A2004，10，21：	1
7	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，3：	1
8	Prevalence of WT1 mutation in a large cohort of patients with steroidresistant and steroid-sensitive nephrotic syndrome 显示文摘	Ruf RG Schuhheiss M Lichtenberger A	2004	Kidney Int2004，66，2：	1
9	The CAIRP ( CAndesartan for ln-stent Restenosis Prevention ) Trial a multicenter study of AT1-receptor blocker therapy in coronary stenting显示文摘	Kramer J Ruf RG Schmidt S	2005	J Invasive Cardiol2005，20，5：	1
10	Patients with mutations in NPHS2(podocin)do not respond to standard steroid treatment of nephrotic syndrome显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，3：	1
11	Patients with mutations in NPHS 2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，3：	1
12	Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome显示文摘	Ruf RG Schultheiss M Lichtenberger A	2004	Kidney Int2004，66，2：	1
13	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome显示文摘	Ruf RG Lichtenberger A Karle SM		0，，03：	1
14	Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome显示文摘	Ruf RG Schultheiss M Lichtenberger A	2004	Kidney Int2004，66，2：	1
15	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，：	1
16	Patients with mutations inN PHS2 ( Podocin ) do not respond to stadard sterioid teatment of nephritic syndrome 显示文摘	Ruf RG Lichtenbegrer A Karle SM	2004	J Am Soc NePhrol2004，15，3：	1
17	Patients with mutations in NPHS2(podocin) do not respond to standard steroid treatmet of nephrotic syndrome 显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephrol2004，15，3：	1
18	Prevalence of WT1 mutations in a large cohort of patients with steroid-resis- tant and steroid-sensitive nephrotic syndrome 显示文摘	Ruf RG Schuhheiss M Lichtenberger A	2004	Kidney Int2004，66，2：	1
19	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome显示文摘	Ruf RG Lichtenberger A Karle SM	2004	J Am Soc Nephroi2004，15，：	1
20	Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome显示文摘	Ruf RG Schultheiss M Lichtenberger A	2004	Kidney Int2004，66，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示